Sign inJoin waitlistJoin the waitlist

Srinivas Tantravahi

Director of Inpatient Operations · Univ of Utah Sch of Med

Credentials: · · · · ·

History

Univ of Utah Sch of Med
Present

Hematology and Medical Oncology
University of Utah Health
2012–2015
Internal Medicine
University of Utah School of Medicine
2009–2012
George Elliot Hospital
2006–2009
Barnsley District General Hospital
2003–2006
Guntur Medical College
1999–2003

Research

BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia
Cancer Cell · 2014 · 291 citations
Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy
European Urology · 2014 · 210 citations
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy
Journal of Clinical Oncology · 2022 · 116 citations

Michael Deininger
13 papers
Neeraj Agarwal
8 papers
TK
Todd Kelley
7 papers
Archana Agarwal
6 papers
Tibor Kovacsovics
5 papers
Toni Choueiri
5 papers
AP
Austin Poole
4 papers · 3 as a fellow
Brian Druker
4 papers
Rodney Miles
4 papers
Shiven Patel
4 papers
Sumanta Pal
4 papers
UV
Ulka Vaishampayan
4 papers

Clinical trials

Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
Principal investigator · Terminated · Phase 2
University of Utah
2019–2025
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Site PI · Recruiting · Phase 2
Karyopharm Therapeutics Inc
2024–2028